Patent ID: 8735356

Claim:
A therapeutic combination consisting essentially of (a) lacosamide; (b) a further compound selected from the group consisting of levetiracetam, gabapentin, carbamazepine, lamotrigine and topiramate; and (c) optionally a pharmaceutically acceptable carrier; wherein when the further compound is: (i) levetiracetam or carbamazepine, then (a) lacosamide and (b) the further compound are present in a fixed-dose ratio of about three parts lacosamide to at least about one part further compound calculated on the ED 50 values of the individual components (a) and (b); or (ii) gabapentin, lamotrigine or topiramate, then (a) lacosamide and (b) the further compound are present in a fixed-dose ratio of about one part lacosamide to at least about one part further compound calculated on the ED 50 values of the individual components (a) and (b), and wherein lacosamide and the further compound are either present in (i) single dose form or (ii) separate dosage forms, wherein the separate dosage forms are co-packaged or separately packaged and available for sale independently of one another but are co-marketed or co-promoted for use in combination with each other.